[go: up one dir, main page]

NO20000731D0 - Neisseria-lactodweeinbindingsprotein - Google Patents

Neisseria-lactodweeinbindingsprotein

Info

Publication number
NO20000731D0
NO20000731D0 NO20000731A NO20000731A NO20000731D0 NO 20000731 D0 NO20000731 D0 NO 20000731D0 NO 20000731 A NO20000731 A NO 20000731A NO 20000731 A NO20000731 A NO 20000731A NO 20000731 D0 NO20000731 D0 NO 20000731D0
Authority
NO
Norway
Prior art keywords
lactodweeinbindingsprotein
neisseria
polypeptides
polynucleotides
disclosed
Prior art date
Application number
NO20000731A
Other languages
English (en)
Other versions
NO20000731L (no
Inventor
Annika Mar Pettersson-Fernholm
Johannes Petrus Mari Tommassen
Original Assignee
Univ Utrecht
Stw Technology Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9717423.9A external-priority patent/GB9717423D0/en
Priority claimed from GBGB9802544.8A external-priority patent/GB9802544D0/en
Application filed by Univ Utrecht, Stw Technology Foundation filed Critical Univ Utrecht
Publication of NO20000731D0 publication Critical patent/NO20000731D0/no
Publication of NO20000731L publication Critical patent/NO20000731L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20000731A 1997-08-15 2000-02-14 Neisseria lactoferinbindingsprotein NO20000731L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9717423.9A GB9717423D0 (en) 1997-08-15 1997-08-15 Vaccine
GBGB9802544.8A GB9802544D0 (en) 1998-02-05 1998-02-05 Vaccine
PCT/EP1998/005117 WO1999009176A1 (en) 1997-08-15 1998-08-10 Neisseria lactoferrin binding protein

Publications (2)

Publication Number Publication Date
NO20000731D0 true NO20000731D0 (no) 2000-02-14
NO20000731L NO20000731L (no) 2000-03-31

Family

ID=26312080

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000731A NO20000731L (no) 1997-08-15 2000-02-14 Neisseria lactoferinbindingsprotein

Country Status (18)

Country Link
US (1) US7105316B2 (no)
EP (1) EP1003874B1 (no)
JP (1) JP2001514894A (no)
KR (1) KR100509712B1 (no)
CN (1) CN1204253C (no)
AT (1) ATE344325T1 (no)
AU (1) AU744733B2 (no)
BR (1) BR9811907A (no)
CA (1) CA2301332A1 (no)
CO (1) CO4810233A1 (no)
DE (1) DE69836333T2 (no)
ES (1) ES2275314T3 (no)
IL (1) IL134436A0 (no)
NO (1) NO20000731L (no)
NZ (1) NZ502750A (no)
PL (1) PL194800B1 (no)
TR (1) TR200000416T2 (no)
WO (1) WO1999009176A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ545647A (en) * 1999-05-19 2008-02-29 Chiron Srl Combination neisserial compositions
GB0007433D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Recombinant transferrin binding proteins
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use
GB0107219D0 (en) * 2001-03-22 2001-05-16 Microbiological Res Authority Immunogenic commensal neisseria sequences
JP4740738B2 (ja) 2002-08-02 2011-08-03 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
WO2005032584A2 (en) 2003-10-02 2005-04-14 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
GB0409748D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Lactoferrin cleavage
US20090123499A1 (en) 2006-06-12 2009-05-14 Nathalie Devos Vaccine
CN102869377A (zh) 2010-03-10 2013-01-09 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
JP2023115806A (ja) * 2022-02-08 2023-08-21 国立大学法人京都工芸繊維大学 ラクトフェリン、コンカナバリンａ、リゾチーム及び／またはヘモグロビンを介して抗体等が固定されたニトロセルロース膜の製造方法及び抗原結合性等の増強方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6048539A (en) * 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein

Also Published As

Publication number Publication date
AU9261398A (en) 1999-03-08
CN1275164A (zh) 2000-11-29
DE69836333D1 (de) 2006-12-14
NZ502750A (en) 2002-03-01
PL194800B1 (pl) 2007-07-31
DE69836333T2 (de) 2007-04-19
CO4810233A1 (es) 1999-06-30
IL134436A0 (en) 2001-04-30
ATE344325T1 (de) 2006-11-15
CA2301332A1 (en) 1999-02-25
JP2001514894A (ja) 2001-09-18
TR200000416T2 (tr) 2000-07-21
EP1003874A1 (en) 2000-05-31
KR100509712B1 (ko) 2005-08-24
CN1204253C (zh) 2005-06-01
AU744733B2 (en) 2002-02-28
EP1003874B1 (en) 2006-11-02
WO1999009176A1 (en) 1999-02-25
NO20000731L (no) 2000-03-31
US7105316B2 (en) 2006-09-12
BR9811907A (pt) 2000-08-15
PL338649A1 (en) 2000-11-06
KR20010022952A (ko) 2001-03-26
ES2275314T3 (es) 2007-06-01
US20040131634A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
WO1998031799A3 (en) Polynucleotides and polypeptides encoding receptors
ATE180261T1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
EP1645631A3 (en) Neisseria antigens and compositions
EP0848062A3 (en) Aspartic protease ASP1
BR9910396A (pt) Polinucleotìdeo(s) e polipeptìdeos basb029 a partirde neisseria meningitidis
NO20000731D0 (no) Neisseria-lactodweeinbindingsprotein
EP0939124A3 (en) MGBP1 sequences
WO1999035266A3 (en) Human urotensin ii
DE69918446D1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
EP0885959A3 (en) Human Wnt-5b protein
EP0943684A3 (en) Frizzled-like polypeptides and polynucleotides
EP0879888A3 (en) Patched-2 polypeptides and polynucleotides and methods for their production
ATE429489T1 (de) Menschliche carnosinase 2
EP0887416A3 (en) Human AFC1
DE60117788D1 (de) Menschliche wingless-änhliche gene
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
NZ514691A (en) Method to type prion proteins
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
EP0875577A3 (en) Novel membrane-type matrix metalloproteinase-5 gene
EP0887415A3 (en) Human RCE1
WO2001043759A3 (en) Use of 11cby popypeptides and polynuceotides
EP0897009A3 (en) HKABY60 polypeptides
EP0897982A3 (en) Sodium bicarbonate co-transporter
WO1998042833A3 (en) Kv potassium channel polypeptides and polynucleotides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application